Michelle Dawson posts

Post published on Twitter/X on 30 Apr 2023 17:44

Twitter/X DOI work crossref Extract quoted in the post External link integrated into the post

Structured cited links

1 cited resource

DOI work Fetched Post crossref

Jennifer Petkovic, Olivia Magwood, Lyubov Lytvyn, Joanne Khabsa, Thomas W. Concannon, Vivian Welch, Alex Todhunter-Brown, Marisha E. Palm, et al. (2023). Key issues for stakeholder engagement in the development of health and healthcare guidelines. Research Involvement and Engagement, 9(1), 27. Springer Science and Business Media LLC.

Publication date
28 Apr 2023
Identifier
10.1186/s40900-023-00433-6
Authors
Jennifer Petkovic, Olivia Magwood, Lyubov Lytvyn, Joanne Khabsa, Thomas W. Concannon, Vivian Welch, Alex Todhunter-Brown, Marisha E. Palm, Elie A. Akl, Lawrence Mbuagbaw, Thurayya Arayssi, Marc T. Avey, Ana Marusic, Richard Morley, Michael Saginur, Nevilene Slingers, Ligia Texeira, Asma Ben Brahem, Soumyadeep Bhaumik, Imad Bou Akl, Sally Crowe, Laura Dormer, Comfort Ekanem, Eddy Lang, Behrang Kianzad, Tanja Kuchenmüller, Lorenzo Moja, Kevin Pottie, Holger Schünemann, Peter Tugwell
Source
Research Involvement and Engagement
Details
9(1), 27
Reference type
article
Publisher
Springer Science and Business Media LLC
Metadata source
crossref

Abstract

Abstract Established in 2015, the Multi-Stakeholder Engagement (MuSE) Consortium is an international network of over 120 individuals interested in stakeholder engagement in research and guidelines. The MuSE group is developing guidance for stakeholder engagement in the development of health and healthcare guideline development. The development of this guidance has included multiple meetings with stakeholders, including patients, payers/purchasers of health services, peer review editors, policymakers, program managers, providers, principal investigators, product makers, the public, and purchasers of health services and has identified a number of key issues. These include: (1) Definitions, roles, and settings (2) Stakeholder identification and selection (3) Levels of engagement, (4) Evaluation of engagement, (5) Documentation and transparency, and (6) Conflict of interest management. In this paper, we discuss these issues and our plan to develop guidance to facilitate stakeholder engagement in all stages of the development of health and healthcare guideline development.

Study authors in this cited reference